The device relies on automated blood-glucose control, designed to mimic the role of the pancreas. This advantage places the work in situations far closer to reality than cultured cells or mouse livers, the usual supports for this type of research.
At Paul Brousse Hospital, researchers keep former diseased human livers instead of discarding them. These organs, which are no longer of use to the patient, are kept alive on a machine for research.
The aim is to test future treatments and future drugs under real conditions, without first trying them directly on the patient. The trials are carried out on a living liver connected to the machine.
These living livers are intended to allow researchers to evaluate future treatments under real conditions, on real human livers.
Researchers at the public hospital will be able to use these organs free of charge. Private pharmaceutical laboratories will have access to them for a fee.
About ten industrial companies have already expressed interest in testing their innovations on these livers kept alive.